Patent directory · USPTO A61K / A61P
Browse patents
Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.
Quick answer
NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.
Patent results
-
US 8187817
Diagnosis, treatment, and prevention of vascular disorders using IL-1 autoantibodies
granted -
US 8187874
Drug discovery method
granted -
US 8188067
Formulations of 6-mercaptopurine
granted -
US 8188049
Peptides having activities of epidermal growth factor and its uses
granted -
US 8188055
Inactivators of O6-alkylguanine-DNA alkyltransferase
granted -
US 8188061
RNAi modulation of APOB and uses thereof
granted -
US 8188072
Benzodiazepinone compounds useful in the treatment of skin conditions
granted -
US 8188149
Use of R(+)-N-propargy1-1-aminoindan to treat or prevent hearing loss
granted -
US 8188214
Brachyury polypeptides and methods for use
granted -
US 8188095
Gyrase inhibitors and uses thereof
granted -
US 8188132
Linked dibenzimidazole derivatives
granted -
US 8188219
Bone morphogenic protein binding peptide
granted -
US 8188221
Peptide homing to brain tumors
granted -
US 8188276
2,4-pyrimidinediamine compounds and their uses
granted -
US 8183207
Treatment of osteolytic disorders and cancer using CSF1R extracellular domain fusion molecules
granted -
US 8183014
High affinity antibodies to human IL-6 receptor
granted -
US 8183338
Sterically hindered poly(ethylene glycol) alkanoic acids and derivatives thereof
granted -
US 8183204
Methods and compositions for increasing skin remodeling
granted -
US 8183282
Therapeutic uses of urolithins
granted -
US 8182807
Method for inhibiting reperfusion injury in the brain
granted -
US 8183274
Treatment of hyperproliferative disorders with diarylhydantoin compounds
granted -
US 8183285
Therapeutic agent for irritable bowel syndrome and methods thereof
granted -
US 8183361
Oligonucleotide-containing pharmacological compositions and their use
granted -
US 8183344
Inactivation resistant factor VIII
granted
Frequently asked questions
What patents are included in this directory?
We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.
How do I search for a patent?
Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.
How is this different from the patent intelligence dashboard?
The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.